Preliminary List of Invited Speaker Titles

(arranged alphabetically according to invited speaker)
Updated 21 June, 2015

 

Subclinical Vascular Damage in Prehypertension
Enrico Agabiti-Rosei, Dept. of Medical and Surgical Sciences, University of Brescia, Italy
Overview of Hypertension Management in Cardio Metabolic Syndrome
Khamis Al-Hashmi, College of Medicine & Health Science, Muscat, Oman
New Therapeutic Options to Treat Atherogenic Lipoproteins
Khalid Al-Rasadi, Sultan Qaboos University Hospital, Muscat, Oman
Overview of Dyslipidemia Management in Cardio Metabolic Syndrome 
Khalid Al-Waili, Sultan Qaboos University Hospital, Muscat, Oman
Metabolic Consequences of Growth Hormone Sensitivity
Fahad Al-Zadjali, College of Medicine & Health Science, Muscat, Oman
Prognostic Role of Endothelial Function Assessment in Prehypertension and Metabolic Syndrome
Giuseppe Ambrosio, Dept. of Cardiology, University of Perugia School of Medicine, Perugia, Italy
The Nutraceuticals: An Alternative or Effective Therapy of Lipid Disorders
Maciej Banach, Dept. of Hypertension, Medical University of Lodz, Poland
Chinese Whispers?:  How dietary research on hypertension and metabolic syndrome are conveyed in the print media
Margo E BarkerHuman Nutrition Unit, Dept of Oncology, University of Sheffield, UK
Total Cardiovascular Risk Evaluation and Management in patients with PAD
Marianne Brodmann, Dept. of Internal Medicine, Medical University Graz, Austria
TBA
John R. Cockcroft, Dept. of Cardiology, Wales Heart Research Institute, University Hospital Cardiff, UK
Oxidative Stress and Epigenetic Signature of Vascular Risk in Obesity and Diabetes
Francesco Cosentino, Dept. of Medicine, Karolinska University Hospital, Solna, Sweden
Differences in Background and the Management of Arterial Hypertension in Youth
Danuta Czarnecka, Dept. of Cardiology,Interventional Elektrocardiology and Hypertension, Jagiellonian University Medical College Kopernika, Kraków, Poland
Vitamin K, Calcium and the Vascular Wall
Peter W. de Leeuw, Dept of Medicine University Hospital Maastricht, The Netherlands
Prime Time to Target Central Arterial Blood Pressure beyond Brachial Blood Pressure?
Daniel A Duprez, Cardiovascular Division, University of Minnesota, Minneapolis, MN, USA
Influence of Prehypertension and Hypertension on the Progression of Coronary Artery Atherosclerosis: Results from the Heinz Nixdorf Recall Study
Raimund Erbel, Dept.of Cardiology, West German Heart Centre Essen, Division of Internal Medicine, University Essen, Germany
PreHypertension and Metabolic Syndrome in Different Populations – Epidemiologic Aspects
Cetin Erol, Ankara University, Faculty of Medicine, bn-i Sina Hospital, Dept. of Cardiology, Ankara, Turkey
Effectiveness of Chlorthalidone/Amiloride versus Losartan in Patients with Stage I Hypertension: Results from the PREVER-Treatment Trial
Flávio D. Fuchs, Hospital de Clinicas de Porto Alegre, Brazil
The Effectiveness of Chlorthalidone plus Amiloride in the Prevention of Hypertension:  Results from the PREVER Prevention Trial
Sandra Fuchs, Hospital de Clinicas de Porto Alegre, Brazil
PreHypertension, Hypertension and Renal Denervation
Guido Grassi, Dept of Internal Medicine, University of Milano Biocca, Milan, Italy
What Are Appropriate Blood Pressure Targets in Diabetic Kidney Disease? Diabetologist Point of View
Janusz Gumprecht, Dept. of Internal Diseases, Diabetology and Nephrology, Medical University of Silesia, Zabrze, Poland
TBA
Tomasz Guzik, Dept. of Internal and Agricultural Medicine, J. Dietl Hospital Jagiellonian University Collegium Medicum, Krakow, Poland
Endothelial Cells – The Interface between Risk Factors and Vascular Disease
Hermann Haller, Dept. of Nephrology and Hypertension Medicine, University of Hannover, Hannover Medical School, Germany
Renal Complications of Diabetes: Glomerular vs Tubular Genetic Implication
Pavel Hamet, University of Montreal and Dept. of Experimental Medicine at McGill University, Canada
Perivascular Fat and Hypertension: The Missing Link?
Anthony M. Heagerty, Dept. of Medicine, Manchester Royal Infirmary, Manchester, UK
Sympathetic Neural Mechanisms Underlying Prehypertension and Metabolic Syndrome
Dagmara Hering, Dept. of Hypertension and Diabetology, Medical University of Gdansk, Poland
New Egyptian Hypertension Guidelines 2014
Mohsen Ibrahim, Dept. of Cardiology, University of Cairo, Egypt
Pre-Levels of CV Risk Factors: Boosting Risk of Events and Deciding Who Should be Treated
Uday Jadhav, Dept. of Cardiology, MGM New Bombay Hospital, Vashi, India
Metabolic Syndrome and Obstructive Sleep Apnea in Pre-Hypertension, Hypertension and Resistant Hypertension
Andrzej Januszewicz, Dept. of Hypertension, Institute of Cardiology, Warsaw, Poland
Hide and Seek, Changing Face of Autonomic Nervous Activity in the Course of Hypertension
Stevo Julius, Division of Cardiovascular Medicine, Internal Medicine and Physiology, University of Michigan, Ann Arbor, MI, USA
The Prognostic Impact of Blood Pressure at Rest and During Ergometer Exercise Through 35-yrs: Of Follow-Up in 2014 Apparently Healthy Middle-Aged Men
Sverre E. Kjeldsen, Dept. of Cardiology, University of Oslo Ullevaal Hospital, Norway
TBA
Basil S. Lewis, Research Affairs and Clinical Cardiovascular Research Institute, Lady Davis Carmel Medical Center, Haifa, Israel
Primary Hypertension in Children and Adolescents – Accelerated Development or Premature Aging?
Mieczysław Litwin, Dept. of Nephrology and Arterial Hypertension, The Children’s Memorial Health Institute, Warsaw, Poland
Metabolic Syndrome in the Population: the PAMELA Data
Giuseppe Mancia, University of Milano Bicocca, Milano, Italy
TBA
Athanasios Manolis, Asklepeion General Hospital, Athens, Greece
TBA
Carmel McEniery, School of Clinical Medicine, Cambridge University, Cambridge, UK
Smoking, Hypertension and Cardiometabolic Risk
Krzysztof Narkiewicz, Dept. of Hypertension and Diabetology, Medical University of Gdansk, Poland
Coronary Microvascular Dysfunction in Patients with Diabetes, Hypertension and Metabolic Syndrome 
Salvatore Novo, Dept. of Internal Medicine and Cardiovascular Disease, University of Palermo, Italy
Who should be Treated in Stage 1 Hypertension of Youth?
Paolo Palatini, Dept. of Clinical and Experimental Medicine, University of Padova, Italy
Blood Pressure Variability: Methodological and Clinical Aspects in Hypertension, Pre-Hypertension and Metabolic Syndrome
Gianfranco Parati, Cardiology Unit, Istituto Auxologica Italiano, Milan and Dept. of Health Sciences, Universita di Milano-Bicocca, Milan, Italy
Insomnia and short sleep duration in prehypertension, hypertension and metabolic syndrome
Aleksander Prejbisz, Warsaw, Poland 
TBA
Karim M. Raafat, Faculty of Pharmacy, Beirut Arab University, Lebanon
Assessing and Improving Adherence in Patients with Hypertension
Brian Rayner, Division of Nephrology & Hypertension, University of Cape Town, South Africa
Total Cardiovascular Risk Evaluation and Management in Type 2 Diabetic Patients
Itamar Raz, Dept. of Medicine, Hadassah University Hospital, Ein-Karem, Jerusalem, Israel
Atherogenic Lipoproteins and Cardio Metabolic Risk
Manfredi Rizzo, University of Palermo, Italy and University of South Carolina, USA
Microvascular Structural Alterations and Tissue Perfusion in Hypertension/Diabetes
Damiano Rizzoni, Dept. of Medical and Surgical Sciences, University of Brescia, Italy
Renal Function and CKD in the Elderly: Disease or not Disease
Alexander R. Rosenkranz, Laboratory of Experimental Nephrology, Department of Internal Medicine IV, Nephrology and Hypertension, Innsbruck Medical University, Innsbruck, Austria
Treating Prehypertension in Older People: Whom and how?
Talma Rosenthal, Sackler Faculty of Medicine, Tel Aviv University, Israel
Primary Aldosteronism: The Epidemics of a Channelopathy
Gian Paolo Rossi, Dept. of Medicine -DIMED – Internal Medicine 4, University Hospital, Padova, Italy
Masked Hypertension, a Challenge in Prehypertension
Luis Ruilope, Hypertension Unit, Hospital 12 de Octubre, Madrid, Spain
Individualisation of Target Levels for Blood Pressure Lowering in Relation to Type of Vascular Complication in Diabetes Mellitus
Guntram Schernthaner, Dept. of Medicine I, Rudolfstiftung Hospital, Vienna, Austria
Cardiovascular Risk Assessment in the Adolescent: The Role of Arterial Function Assessment
Giuseppe Schillaci, Dept. of Medicine and Unit of Internal Medicine Terni University Hospital, Italy
Emerging Vascular Biomarkers in Arterial Aging or Arterial Stiffness and Risk Prediction in Prediabetes and Metabolic Syndrome
Arno Schmidt-Trucksass, Division Sports and Exercise Medicine, Medical Faculty, University Basel, Switzerland
Antiphospholipid Syndrome as the Total Cardiovascular Risk Evaluation and Management
Ljudmila Stojanovich, Scientific Research Dept. Bezhanijska Kosa, University Medical Center, Belgrade University, Serbia
Vascular Damage as a Cause and Consequence of Hypertension
Rhian M. Touyz, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, UK
Endothelial Dysfunction in Hypertension: Mechanisms and Clinical Significance
Stefano Taddei, Dept. of Clinical and Experimental Medicine, University of Pisa, Italy
Stimulating the Protective Arm of the Renin-Angiotensin System: A Novel Approach to Cardio-Metabolic Prevention and Organ Protection 
Thomas Unger, Dept. of Molecular Genetics, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, The Netherlands
Arterial Ageing in Hypertension
Charalambos Vlachopoulos, 1st Department of Cardiology, University of Athens Medical School, Greece
Microalbuminuria and Renal Function as Indicators of Cardiovascular Risk
Bruno Watschinger, Dept. of Medicine, University of Vienna Medical School, Vienna, Austria
24 hour Measurement of Pulsatile Hemodynamics: The Logical Next Step
Thomas Weber, Dept. of Cardiology, Klinikum Wels-Grieskirchen, Wels, Austria
Aortic Stiffness and Metabolic Syndrome Components
Ian B. Wilkinson, Clinical Pharmacology Unit, Addenbrooke’s Hospital, Cambridge, UK
Management of High Normal Blood Pressure: Is Antihypertensive Agent a Choice?
Yuqing Zhang, Division of Hypertension, Fu Wai Hospita, Beijing, China
Treatment of Hypertension and CMS: Is it enough for Arterial Protection? Arterial Destiffening a New Goal
Reuven Zimlichman, Sackler Faculty of Medicine, Tel Aviv University, The E. Wolfson Medical Center, Holon, Israel